Most Recent Articles about Pacific Biosciences of California
LMNX or PACB: Which is a Better MedTech Investment Pick? http://www.zacks.com/stock/news/345680/lmnx-or-pacb-which-is-a-better-medtech-investment-pick?cid=CS-ZC-FT-345680 Jan 04, 2019 - Luminex (LMNX) scores higher than Pacific Biosciences (PACB) considering growth projections and fundamentals.
An Easy Way To Arbitrage Profits: The GDL Fund https://seekingalpha.com/article/4229948-easy-way-arbitrage-profits-gdl-fund?source=feed_tag_editors_picks Dec 24, 2018 - Strategy for profiting in up, sideways, or down markets. Capture a double discount – deal spreads plus retail investor panic. This worked well in 2009 and could work well in 2019.
Here's Why You Should Hold Pacific Biosciences (PACB) Now http://www.zacks.com/stock/news/341454/heres-why-you-should-hold-pacific-biosciences-pacb-now?cid=CS-ZC-FT-341454 Dec 06, 2018 - Pacific Biosciences (PACB) is likely to gain from strong prospects in the Sequel System platform. However, the company faces cutthroat competition in the DNA sequencing market.

Related Companies

Name Exchange Price Mkt Cap
QTRX Quanterix Corporation NASDAQ $16.52 $365.09M
FLDM Fluidigm Corporation NASDAQ $8.01 $313.7M
AXDX Accelerate Diagnostics, Inc. NASDAQ $21 $1.14B
HBIO Harvard Bioscience, Inc. NASDAQ $5.35 $195.7M
EYPT EyePoint Pharmaceuticals, Inc. NASDAQ $2.35 $175.1M
Sector: Capital Goods > Industry: Biotechnology: Laboratory Analytical Instruments